Histoplasma capsulatum Antigen, Urine
p16 by Immunohistochemistry (CINtec® and CINtec® PLUS Cytology)
Adenocarcinoma of stomach (Gastric adenocarcinoma)
Leishmaniasis
Heparin-PF4 Antibody (HIT)
X-Linked Adrenoleukodystrophy (ABCD1) Gene Mutation Analysis, Blood
Myeloperoxidase (MPO) Antibody, IgG
Cardiovascular risk assessment
Haemophilus influenzae Type B Antibody, IgG
LDS
Sign up
Log in
LDS
/
Medical Tests
/
VENTANA® MET (SP44) RxDx IHC Assay for non-squamous, non-small cell lung cancer (NSQ-NSCLC)
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
VENTANA® MET (SP44) RxDx IHC Assay for non-squamous, non-small cell lung cancer (NSQ-NSCLC)
Medical Test
Interpretation
Access to
VENTANA® MET (SP44) RxDx IHC Assay for non-squamous, non-small cell lung cancer (NSQ-NSCLC)
is restricted.
Sign up now
Loading...